Cost awareness of consumables and medications used by anesthesia staff

Authors

  • ประเสริฐ สวัสดิ์วิภาชัย
  • อภิชาต ศุภธรรมวิทย์
  • สถิตย์ ชัยรัตนวนิช

DOI:

https://doi.org/10.14456/jmu.2014.2

Keywords:

cost awareness, price tag, cost reduction, anesthesia staff, usage behavior, cost analysis, price label

Abstract

          Background : Labor costs in developing countries are less substantial when compared to costs related to imported pharmaceuticals and consumables. Locally manufactured high quality products are now also increasingly available in many Asian countries and less expensive.  Many healthcare providers are not aware of actual costs of what they use daily.

          Objective : to learn whether cost awareness can affect usage behavior and result in health care  cost reduction.

          Methods : A single center, prospective observational study conducted between 2008 and 2009. The pre-study questionnaire was issued to 136 participants (anesthesiologists, nurse anesthetists and anesthesiology residents) to assess their cost awareness of anesthesia consumables and pharmaceuticals. Price tags were then affixed on each medication and consumable, which could be clearly seen in daily practice.  This was continued for 12 months. At the end of one year, a post-study questionnaire was issued to 125 participants. The stock data of used item was also recorded using time series analysis.

          Results : Post study test data revealed improvement of cost awareness in  only 3 out of a total of 25 sample items studied among anesthesiology staff but not among  trainees (residents).   Data showed no statistically significant changes (no reduction and no increment) between with and without intervention.

Conclusions : Cost awareness of anesthesia consumables and medications among certain group of anesthesia staffs (non-trainees) does not change usage behavior which resulted in no change of total anesthesia cost.

References

1. Hawkes C, Miller D, Martineau R. Hull K,Hopkins H, Tierney M. Evaluation of cost minimization strategies of anaesthetic drugs in a tertiary care hospital. Can J Anaesth 1994:41(10):894 - 901.

2. Tsai MH. Ten tips in providing value inoperating room management. Anesthesiology Clinic. 2008;26(4):765 - 83.

3. Lubarsky DA, Glass PS, Ginsberg B, DearGL, Dentz ME,Gan TJ, et al. The successful implementation of pharmaceutical practice guidelines. Analysis of associated outcomes and cost savings. SWiPE Group. Systematic Withdrawal of Perioperative Expenses. Anesthesiology1997;86(5):1145 - 1160.

4. Lethbridge JR, Walker JS. Cost of anaesthetic drugs and clinical budgeting. Br Med J . (ClinRes Ed) 1986;293(6561):1587 - 1588.

5. Pedersen FM, Nielsen J, Ibsen M, Guldager H. Low-flow isoflurane-nitrous oxide anaesthesia offers substantial economic advantages over high- and medium-flow isoflurane-nitrous oxide anaesthesia. ActaAnaesthesiolScand 1993:37(5)509 -512. 6. Cotter SM, Petros AJ, Dore CJ, Barber ND, White DC.Low-flow anaesthesia. Practice, cost implications and acceptability. Anaesthesia 1991;46(12):1009-1012.

7. Crozier TA, Kettler D. Cost effectiveness of general anesthesia: inhalation vsi.v. Br J Anaesth 1999:83:(4):547-548.

8. Smith I, Terhoeve PA, Hennart D, Feiss P, Harmer M, Pourriat JL, Johnson IA. A multicentre comparison of the costs of anaesthesia with sevofluraneor propofol. Br JAnaesth 1999:83(4):564 - 570.

9. Epple J, Kubitz J, Schmidt H, Motsch J, Böttiger BW, Martin E, Bach A. Comparative analysis of costs of total intravenous anaesthesia with propofol and remifentanil vs. balanced anaesthesia with isoflurane and fentanyl. Eur J Anaesthesiol 2001;18(1):20 - 28.

10. Schlünzen L, Simonsen MS, SpangsbergNL, Carlsson P. Cost consciousness among anaesthetic staff. ActaAnaesthesiolScand 1999:43(2):202-205.

11. Bailey CR, Ruggier R, Cashman JN. Anaesthesia: cheap at twice the price? Staff awareness, cost comparisons and recommendations for economic savings. Anaesthesia 1993;48(10):906-9.

12. Hadjipavlou M, Bailey CR. ‘The price of everything and the value of nothing’: cost awareness in anaesthesia. J PerioperPract 2010;20(12):446-50.

13. Eger EI, White PF, Bogetz MS. Clinical and economic factors important to anaesthetic choice for day-case surgery. Pharmacoeconomics 2000:17(3):245-62.

14. Smith I. Cost considerations in the use of anaesthetic drugs. Pharmacoeconomics 2001;19(5 pt 1):469-81.

Downloads

Published

2014-06-30

Issue

Section

Research Articles